Diclofenac Market size is projected to reach revenue of $5.64 billion by 2025,growing at a CAGR of 3.87% during the forecast period 2020-2025. Diclofenac is a Nonsteroidal anti-inflammatory drug (NSAID) and Diclofenac Sodium is also a Nonsteroidal anti-inflammatory drug (NSAID) which are used in the form of eye drop that helps to treat swelling of eye after eye surgery. It is used to reduce moderate pain, swelling, stiffness and inflammation.Increasing prevalence of autoimmune and respiratory conditions and increasing adoption of anti-inflammatory drugs are the major factors driving the growth of the market. Growing awareness about anti-inflammatory drugs and Development in R&D activities is set to further enhance the overall market demand of diclofenac during the forecast period 2020-2025.
Report Coverage
The report: “Diclofenac Market Forecast (2020-2025)”, by IndustryARC,covers an in-depth analysis of the following segments of the Diclofenac Market.
By Administration- Oral, injection, Eye drops, Gel and Others
By Indication- Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid Arthritis, Migraine, Dental Pain and Others
By Distribution- Hospitals and Pharmacy
By Geography- North America, Europe, Asia Pacific, and Rest of the World.
Key Takeaways
• North America dominates the Diclofenac Market owing to well established healthcare facilities, favorable reimbursement policies, increasing awareness about anti-inflammatory drugs that are in the market and attractive government initiatives.
• Increasing prevalence of autoimmune and respiratory conditions such as arthritis, Dental painis likely to aid in the market growth of diclofenac.
• Detailed analysis on the Strength, Weakness and opportunities of the prominent players operating in the market will be provided in the Diclofenac Market report.
• Unwanted effects and health issue can create a hurdle in the growth of market in coming future.
Formulation Type- Segment Analysis
Based on the formulation type, Diclofenac market is segmented into Oral, injection, Eye drops, Gel and Others.Oral Formulation heldthe largest share in the Diclofenac market in 2019 and is estimated to grow at a CAGR of 2.6% during the forecast period 2020-2025. Diclofenac are widely available at affordable prices and adoption of these drugs has been increasing over the years owing to relief in pain and reduces inflammatory disorders.
Indication - Segment Analysis
Based on the indication, Diclofenac market is segmented by Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid Arthritis, Migraine, Dental pain and Others. Osteoarthritis, dysmenorrhea, and inflammatory disorders held the largest share in the Diclofenac Market in 2019 and is estimated to grow at a CAGR of 2.6% during the forecast period 2020-2025.High demand for better and novel anti-inflammatory therapeutics and growing awareness about anti-inflammatory Drugs are the major factors resulting into the growth of the market. Adoption of diclofenac has been increasing owning to effective pain relief and reduced Osteoarthritis pain in joints.
Geography- Segment Analysis
North America dominated the Diclofenac Market accounting for more than 36.4% of the overall market. Robust healthcare infrastructure combined with focus on development of new devices along with improved diagnosis among the patients are helping in this region market growth. The favorable reimbursements policies and presence of key players in this region is also supporting the growth of the Diclofenac market in this region.
However, Asia-Pacific is estimated to grow at a higher CAGR during the forecast period 2020-2025. This is owing to the rise in incidence of inflammation disorders and increase in healthcare expenditure. Moreover, there has been a rise in the number of patients suffering from chronic and neuropathicpain, is set to play an important role for the growth of this region.
"We also publish more than 100 reports every month in “Lifesciences and Healthcare”, Go through the Domain if there are any other areas for which you would like to get a market research study."
Comments
Post a Comment